These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14665353)

  • 1. Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity?
    Bozlu M; Ulusoy E; Doruk E; Cayan S; Canpolat B; Schellhammer PF; Akbay E
    Urology; 2003 Dec; 62(6):1050-3. PubMed ID: 14665353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preventive effect of tamsulosin on voiding dysfunction after prostate biopsy: a prospective, open-label, observational study.
    Chung SJ; Jung SI; Ryu JW; Hwang EC; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2015 May; 47(5):711-5. PubMed ID: 25812823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alpha-blocker use on morbidity and lower urinary tract symptoms in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Salar R; Erbay G
    Urologia; 2022 Nov; 89(4):541-546. PubMed ID: 34965804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of alpha blocker treatment prior to prostate biopsy on voiding functions, pain scores and health-related quality-of-life outcomes: A prospective randomized trial.
    Sefik E; Eker A; Gunlusoy B; Celik S; Bozkurt IH; Basmaci I; Polat S; Degirmenci T; Ceylan Y
    Prog Urol; 2020 Mar; 30(4):198-204. PubMed ID: 31983605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy.
    Djavan B; Ghawidel K; Basharkhah A; Hruby S; Bursa B; Marberger M
    Urology; 1999 Jul; 54(1):73-80. PubMed ID: 10414730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Voiding Impairment after Prostate Biopsy and the Effect of Doxazosin Treatment: Outcomes from a Regional Cancer Center.
    Zheng Y; Bai F; Zhang N; Wu H
    Urol Int; 2022; 106(1):97-102. PubMed ID: 34404051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Medium-to-long-term Use of Tolterodine Extended Release with or without Tamsulosin in Patients with Benign Prostate Hyperplasia and Larger Prostate Size: A Double-blind, Placebo-controlled, Randomized Clinical Trial.
    Cai JL; Zhou Z; Yang Y; Yan YF; Jing S; Na YQ
    Chin Med J (Engl); 2016 Dec; 129(24):2899-2906. PubMed ID: 27958220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Galbreath RW
    Urology; 2002 Oct; 60(4):650-5. PubMed ID: 12385927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone? : A prospective, randomized, controlled trial.
    Yan M; Xue P; Wang K; Gao G; Zhang W; Sun F
    Strahlenther Onkol; 2017 Sep; 193(9):714-721. PubMed ID: 28612083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial.
    Djavan B; Shariat S; Fakhari M; Ghawidel K; Seitz C; Partin AW; Roehrborn CG; Marberger M
    Urology; 1999 Feb; 53(2):251-9. PubMed ID: 9933035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of prostate volume with voiding impairment and deterioration in quality of life after prostate biopsy.
    Aktas BK; Bulut S; Gokkaya CS; Ozden C; Salar R; Aslan Y; Baykam MM; Memis A
    Urology; 2014 Mar; 83(3):617-21. PubMed ID: 24387931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition zone ratio and prostate-specific antigen density as predictors of the response of benign prostatic hypertrophy to alpha blocker and anti-androgen therapy.
    Kurita Y; Masuda H; Suzuki K; Fujita K; Kawabe K
    Br J Urol; 1997 Jul; 80(1):78-83. PubMed ID: 9240185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any priority between the alpha blockers on voiding functions after transrectal ultrasound guided prostate biopsy?
    Efesoy O; Saylam B; Tek M; Bozlu M; Akbay E
    Turk J Urol; 2021 Mar; 47(2):137-143. PubMed ID: 33819444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
    Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery.
    Jang JH; Kang SB; Lee SM; Park JS; Kim DW; Ahn S
    World J Surg; 2012 Nov; 36(11):2730-7. PubMed ID: 22806208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
    Elshaikh MA; Ulchaker JC; Reddy CA; Angermeier KW; Klein EA; Chehade N; Altman A; Ciezki JP
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):164-9. PubMed ID: 15850917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.